| Year |
Citation |
Score |
| 2015 |
Barrett MJ, Hac NE, Yan G, Harrison MB, Wooten GF. Relationship of age of onset and family history in Parkinson disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 733-5. PMID 25737058 DOI: 10.1002/mds.26166 |
0.303 |
|
| 2014 |
Morgan JC, Currie LJ, Harrison MB, Bennett JP, Trugman JM, Wooten GF. Mortality in levodopa-treated Parkinson's disease. Parkinson's Disease. 2014: 426976. PMID 24616821 DOI: 10.1155/2014/426976 |
0.391 |
|
| 2011 |
Claassen DO, van den Wildenberg WP, Ridderinkhof KR, Jessup CK, Harrison MB, Wooten GF, Wylie SA. The risky business of dopamine agonists in Parkinson disease and impulse control disorders. Behavioral Neuroscience. 125: 492-500. PMID 21604834 DOI: 10.1037/A0023795 |
0.355 |
|
| 2009 |
Harrison MB, Wylie SA, Frysinger RC, Patrie JT, Huss DS, Currie LJ, Wooten GF. UPDRS activity of daily living score as a marker of Parkinson's disease progression. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 224-30. PMID 18951537 DOI: 10.1002/Mds.22335 |
0.359 |
|
| 2008 |
Latourelle JC, Sun M, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, Shill HA, et al. The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study. Bmc Medicine. 6: 32. PMID 18986508 DOI: 10.1186/1741-7015-6-32 |
0.559 |
|
| 2008 |
McNicoll CF, Latourelle JC, MacDonald ME, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, et al. Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1596-601. PMID 18649400 DOI: 10.1002/Mds.22186 |
0.568 |
|
| 2008 |
DeStefano AL, Latourelle J, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts R, Guttman M, Racette BA, Perlmutter JS, Marlor L, Shill HA, et al. Replication of association between ELAVL4 and Parkinson disease: the GenePD study. Human Genetics. 124: 95-9. PMID 18587682 DOI: 10.1007/S00439-008-0526-4 |
0.509 |
|
| 2008 |
Kieburtz K, Tilley B, Ravina B, Galpern W, Shannon K, Tanner C, Wooten GF. A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-Month results Clinical Neuropharmacology. 31: 141-150. PMID 18520981 DOI: 10.1097/Wnf.0B013E3181342F32 |
0.359 |
|
| 2008 |
Tobin JE, Latourelle JC, Lew MF, Klein C, Suchowersky O, Shill HA, Golbe LI, Mark MH, Growdon JH, Wooten GF, Racette BA, Perlmutter JS, Watts R, Guttman M, Baker KB, et al. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study. Neurology. 71: 28-34. PMID 18509094 DOI: 10.1212/01.Wnl.0000304051.01650.23 |
0.525 |
|
| 2007 |
Kieburtz K, Ravina B, Galpern WR, Tilley B, Shannon K, Tanner C, Wooten GF, Hamill R, Sage JI, Kosa E, Watts RL, Stover NR, McMurray R, Lew MF, Kawai C, et al. A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease Neurology. 68: 20-28. PMID 17200487 DOI: 10.1212/01.Wnl.0000250355.28474.8E |
0.337 |
|
| 2006 |
Wilk JB, Tobin JE, Suchowersky O, Shill HA, Klein C, Wooten GF, Lew MF, Mark MH, Guttman M, Watts RL, Singer C, Growdon JH, Latourelle JC, Saint-Hilaire MH, DeStefano AL, et al. Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study. Neurology. 67: 2206-10. PMID 17190945 DOI: 10.1212/01.Wnl.0000249149.22407.D1 |
0.496 |
|
| 2006 |
Sun M, Latourelle JC, Wooten GF, Lew MF, Klein C, Shill HA, Golbe LI, Mark MH, Racette BA, Perlmutter JS, Parsian A, Guttman M, Nicholson G, Xu G, Wilk JB, et al. Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. Archives of Neurology. 63: 826-32. PMID 16769863 DOI: 10.1001/Archneur.63.6.826 |
0.52 |
|
| 2005 |
Karamohamed S, Latourelle JC, Racette BA, Perlmutter JS, Wooten GF, Lew M, Klein C, Shill H, Golbe LI, Mark MH, Guttman M, Nicholson G, Wilk JB, Saint-Hilaire M, DeStefano AL, et al. BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study. Neurology. 65: 1823-5. PMID 16344533 DOI: 10.1212/01.Wnl.0000187075.81589.Fd |
0.317 |
|
| 2005 |
Karamohamed S, Golbe LI, Mark MH, Lazzarini AM, Suchowersky O, Labelle N, Guttman M, Currie LJ, Wooten GF, Stacy M, Saint-Hilaire M, Feldman RG, Liu J, Shoemaker CM, Wilk JB, et al. Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson's disease from the GenePD study. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 1188-91. PMID 15966003 DOI: 10.1002/Mds.20515 |
0.51 |
|
| 2004 |
Montgomery EB, Pan T, Le W, Jankovic J, Ahlskog JE, Wooten GF, Albin RL, Frey KA. Slowing Parkinson's disease progression: Recent dopamine agonist trials [3] (multiple letters) Neurology. 62: 343-345. DOI: 10.1212/Wnl.62.2.343 |
0.332 |
|
| 2003 |
Karamohamed S, DeStefano AL, Wilk JB, Shoemaker CM, Golbe LI, Mark MH, Lazzarini AM, Suchowersky O, Labelle N, Guttman M, Currie LJ, Wooten GF, Stacy M, Saint-Hilaire M, Feldman RG, et al. A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study. Neurology. 61: 1557-61. PMID 14663042 DOI: 10.1212/01.Wnl.0000095966.99430.F4 |
0.495 |
|
| 2002 |
DeStefano AL, Lew MF, Golbe LI, Mark MH, Lazzarini AM, Guttman M, Montgomery E, Waters CH, Singer C, Watts RL, Currie LJ, Wooten GF, Maher NE, Wilk JB, Sullivan KM, et al. PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study. American Journal of Human Genetics. 70: 1089-95. PMID 11920285 DOI: 10.1086/339814 |
0.559 |
|
| 2002 |
Maher NE, Golbe LI, Lazzarini AM, Mark MH, Currie LJ, Wooten GF, Saint-Hilaire M, Wilk JB, Volcjak J, Maher JE, Feldman RG, Guttman M, Lew M, Waters CH, Schuman S, et al. Epidemiologic study of 203 sibling pairs with Parkinson's disease: the GenePD study. Neurology. 58: 79-84. PMID 11781409 DOI: 10.1212/Wnl.58.1.79 |
0.515 |
|
| 2001 |
DeStefano AL, Golbe LI, Mark MH, Lazzarini AM, Maher NE, Saint-Hilaire M, Feldman RG, Guttman M, Watts RL, Suchowersky O, Lafontaine AL, Labelle N, Lew MF, Waters CH, Growdon JH, ... ... Wooten GF, et al. Genome-wide scan for Parkinson's disease: the GenePD Study. Neurology. 57: 1124-6. PMID 11571351 DOI: 10.1212/Wnl.57.6.1124 |
0.488 |
|
| 1998 |
Swerdlow RH, Parks JK, Davis JN, Cassarino DS, Trimmer PA, Currie LJ, Dougherty J, Bridges WS, Bennett JP, Wooten GF, Parker WD. Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family. Annals of Neurology. 44: 873-81. PMID 9851431 DOI: 10.1002/Ana.410440605 |
0.341 |
|
| 1997 |
Wooten GF, Currie LJ, Bennett JP, Harrison MB, Trugman JM, Parker WD. Maternal inheritance in Parkinson's disease. Annals of Neurology. 41: 265-8. PMID 9029076 DOI: 10.1002/Ana.410410218 |
0.334 |
|
| 1987 |
Sanes DH, Geary WA, Wooten GF, Rubel EW. Quantitative distribution of the glycine receptor in the auditory brain stem of the gerbil. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 7: 3793-802. PMID 2890726 DOI: 10.1523/Jneurosci.07-11-03793.1987 |
0.595 |
|
| 1987 |
Sanes DH, Wooten GF. Development of glycine receptor distribution in the lateral superior olive of the gerbil. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 7: 3803-11. PMID 2824718 DOI: 10.1523/Jneurosci.07-11-03803.1987 |
0.534 |
|
| 1986 |
Trugman JM, Geary WA, Wooten GF. Localization of D-2 dopamine receptors to intrinsic striatal neurones by quantitative autoradiography. Nature. 323: 267-9. PMID 3762674 DOI: 10.1038/323267A0 |
0.334 |
|
| 1986 |
Bennett JP, Wooten GF. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease. Annals of Neurology. 19: 378-83. PMID 3707090 DOI: 10.1002/Ana.410190412 |
0.322 |
|
| 1986 |
Trugman JM, Wooten GF. The effects of L-DOPA on regional cerebral glucose utilization in rats with unilateral lesions of the substantia nigra. Brain Research. 379: 264-74. PMID 3527339 DOI: 10.1016/0006-8993(86)90780-8 |
0.311 |
|
| 1982 |
Wooten GF, Horne MK. A new autoradiographic approach for imaging forebrain dopamine distribution. Annals of Neurology. 12: 163-8. PMID 6812487 DOI: 10.1002/Ana.410120206 |
0.305 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2002 |
Maher NE, Currie LJ, Lazzarini AM, Wilk JB, Taylor CA, Saint-Hilaire MH, Feldman RG, Golbe LI, Wooten GF, Myers RH. Segregation analysis of Parkinson disease revealing evidence for a major causative gene. American Journal of Medical Genetics. 109: 191-7. PMID 11977177 DOI: 10.1002/Ajmg.10335 |
0.299 |
|
| 1992 |
Pollack AE, Wooten GF. Differential regulation of striatal preproenkephalin mRNA by D1 and D2 dopamine receptors. Brain Research. Molecular Brain Research. 12: 111-9. PMID 1312196 DOI: 10.1016/0169-328X(92)90074-L |
0.296 |
|
| 1988 |
Wooten GF. Progress in understanding the pathophysiology of treatment-related fluctuations in Parkinson's disease. Annals of Neurology. 24: 363-5. PMID 3067652 DOI: 10.1002/Ana.410240302 |
0.295 |
|
| 1992 |
Pollack AE, Wooten GF. D2 dopaminergic regulation of striatal preproenkephalin mRNA levels is mediated at least in part through cholinergic interneurons. Brain Research. Molecular Brain Research. 13: 35-41. PMID 1315917 DOI: 10.1016/0169-328X(92)90042-A |
0.29 |
|
| 1992 |
Harrison MB, Wiley RG, Wooten GF. The time course of changes in D1 and D2 receptor binding in the striatum following a selective lesion of striatonigral neurons. Brain Research. 596: 330-6. PMID 1334779 DOI: 10.1016/0006-8993(92)91567-X |
0.288 |
|
| 1990 |
Harrison MB, Wiley RG, Wooten GF. Selective localization of striatal D1 receptors to striatonigral neurons. Brain Research. 528: 317-22. PMID 2148707 DOI: 10.1016/0006-8993(90)91674-6 |
0.288 |
|
| 1992 |
Harrison MB, Wiley RG, Wooten GF. Changes in D2 but not D1 receptor binding in the striatum following a selective lesion of striatopallidal neurons. Brain Research. 590: 305-10. PMID 1422839 DOI: 10.1016/0006-8993(92)91111-Q |
0.288 |
|
| 1993 |
Pollack AE, Harrison MB, Wooten GF, Fink JS. Differential localization of A2a adenosine receptor mRNA with D1 and D2 dopamine receptor mRNA in striatal output pathways following a selective lesion of striatonigral neurons. Brain Research. 631: 161-6. PMID 8298989 DOI: 10.1016/0006-8993(93)91204-6 |
0.287 |
|
| 1980 |
Wooten GF, Collins RC. Regional brain glucose utilization following intrastriatal injections of kainic acid. Brain Research. 201: 173-84. PMID 7417829 DOI: 10.1016/0006-8993(80)90782-9 |
0.285 |
|
| 1976 |
Ciaranello RD, Wooten GF, Axelrod J. Regulation of rat adrenal dopamine beta-hydroxylase. II. Receptor interaction in the regulation of enzyme synthesis and degradation. Brain Research. 113: 349-62. PMID 182323 DOI: 10.1016/0006-8993(76)90946-X |
0.283 |
|
| 2003 |
Wooten GF. Agonists vs levodopa in PD: the thrilla of whitha. Neurology. 60: 360-2. PMID 12578913 DOI: 10.1212/WNL.60.3.360 |
0.282 |
|
| 1989 |
Bekenstein JW, Wooten GF. Hemicholinium-3 binding sites in rat brain: a quantitative autoradiographic study. Brain Research. 481: 97-105. PMID 2706469 DOI: 10.1016/0006-8993(89)90488-5 |
0.281 |
|
| 1988 |
Cutlip AC, Lenn NJ, Wooten GF. Behavioral and metabolic alterations in the opiate withdrawal syndrome induced by lesions of fasciculus retroflexus. Brain Research. 451: 54-8. PMID 3251604 DOI: 10.1016/0006-8993(88)90748-2 |
0.278 |
|
| 2009 |
Wylie SA, van den Wildenberg WP, Ridderinkhof KR, Bashore TR, Powell VD, Manning CA, Wooten GF. The effect of Parkinson's disease on interference control during action selection. Neuropsychologia. 47: 145-57. PMID 18761363 DOI: 10.1016/J.Neuropsychologia.2008.08.001 |
0.276 |
|
| 2007 |
Ozelius LJ, Foroud T, May S, Senthil G, Sandroni P, Low PA, Reich S, Colcher A, Stern MB, Ondo WG, Jankovic J, Huang N, Tanner CM, Novak P, Gilman S, ... ... Wooten GF, et al. G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with multiple system atrophy. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 546-9. PMID 17230458 DOI: 10.1002/Mds.21343 |
0.274 |
|
| 1973 |
Wooten GF, Eldridge R, Axelrod J, Stern RS. Elevated plasma dopamine- -hydroxylase activity in autosomal dominant torsion dystonia. The New England Journal of Medicine. 288: 284-7. PMID 4682668 DOI: 10.1056/Nejm197302082880604 |
0.272 |
|
| 2008 |
Holroyd S, Currie LJ, Wooten GF. Validity, sensitivity and specificity of the mentation, behavior and mood subscale of the UPDRS. Neurological Research. 30: 493-6. PMID 18241530 DOI: 10.1179/016164107X251772 |
0.272 |
|
| 2009 |
Wylie SA, van den Wildenberg WP, Ridderinkhof KR, Bashore TR, Powell VD, Manning CA, Wooten GF. The effect of speed-accuracy strategy on response interference control in Parkinson's disease. Neuropsychologia. 47: 1844-53. PMID 19428416 DOI: 10.1016/J.Neuropsychologia.2009.02.025 |
0.263 |
|
| 1983 |
Geary WA, Wooten GF. A behavioral and 2-deoxyglucose autoradiographic study of the effects of cumulative morphine dose on naloxone precipitated withdrawal in the rat. Brain Research. 275: 117-26. PMID 6684966 DOI: 10.1016/0006-8993(83)90423-7 |
0.263 |
|
| 1984 |
Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Annals of Neurology. 15: 217-27. PMID 6609679 DOI: 10.1002/Ana.410150302 |
0.262 |
|
| 1986 |
Geary WA, Wooten GF. Time action profiles of regional cerebral glucose utilization during naloxone-precipitated morphine withdrawal. Brain Research. 399: 181-4. PMID 3801919 DOI: 10.1016/0006-8993(86)90616-5 |
0.261 |
|
| 2001 |
Swerdlow RH, Parker WD, Currie LJ, Bennett JP, Harrison MB, Trugman JM, Wooten GF. Gender ratio differences between Parkinson's disease patients and their affected relatives. Parkinsonism & Related Disorders. 7: 129-133. PMID 11248594 DOI: 10.1016/S1353-8020(00)00029-8 |
0.26 |
|
| 1990 |
Bekenstein JW, Bennett JP, Wooten GF, Lothman EW. Autoradiographic evidence that NMDA receptor-coupled channels are located postsynaptically and not presynaptically in the perforant path-dentate granule cell system of the rat hippocampal formation. Brain Research. 514: 334-42. PMID 2162712 DOI: 10.1016/0006-8993(90)91429-K |
0.259 |
|
| 1974 |
Naftchi NE, Wooten GF, Lowman EW, Axelrod J. Increased serum dopamine-β-hydroxylase activity during neurogenic hypertension in quadriplegia Biochemical Pharmacology. 23: 957-961. DOI: 10.1016/0006-2952(74)90169-5 |
0.257 |
|
| 1985 |
Geary WA, Wooten GF. Dose effects of naloxone on fixed morphine dependence: simultaneous behavioral and 2-deoxyglucose study in the rat. Brain Research. 332: 69-78. PMID 4039615 DOI: 10.1016/0006-8993(85)90390-7 |
0.256 |
|
| 1993 |
Adams RE, Wooten GF. Is morphine dependence mediated exclusively by the Mu receptor? Neurochemical Research. 18: 1041-5. PMID 8255352 DOI: 10.1007/Bf00966681 |
0.255 |
|
| 1972 |
Thoa NB, Wooten GF, Axelrod J, Kopin IJ. Inhibition of release of dopamine- -hydroxylase and norepinephrine from sympathetic nerves by colchicine, vinblastine, or cytochalasin-B (hypogastric nerve stimulation-exocytosis-microtubules-microfilaments-guinea pig). Proceedings of the National Academy of Sciences of the United States of America. 69: 520-2. PMID 4333989 DOI: 10.1073/Pnas.69.2.520 |
0.254 |
|
| 1973 |
Wooten GF. Subcellular distribution and rapid axonal transport of dopamine- -hydroxylase. Brain Research. 55: 491-4. PMID 4123466 DOI: 10.1016/0006-8993(73)90320-X |
0.254 |
|
| 1989 |
Wooten GF, Trugman JM. The dopamine motor system. Movement Disorders : Official Journal of the Movement Disorder Society. 4: S38-47. PMID 2657409 DOI: 10.1002/Mds.870040506 |
0.249 |
|
| 1989 |
Kapur J, Bennett JP, Wooten GF, Lothman EW. Evidence for a chronic loss of inhibition in the hippocampus after kindling: biochemical studies. Epilepsy Research. 4: 100-8. PMID 2792064 DOI: 10.1016/0920-1211(89)90014-4 |
0.248 |
|
| 2001 |
Wooten GF. Anatomy and function of dopamine receptors: understanding the pathophysiology of fluctuations in Parkinson's disease. Parkinsonism & Related Disorders. 8: 79-83. PMID 11489671 DOI: 10.1016/S1353-8020(01)00020-7 |
0.247 |
|
| 1990 |
Adams RE, Wooten GF. Dependence and withdrawal following intracerebroventricular and systemic morphine administration: functional anatomy and behavior. Brain Research. 518: 6-10. PMID 2390728 DOI: 10.1016/0006-8993(90)90946-9 |
0.247 |
|
| 2001 |
Swerdlow RH, Wooten GF. A novel deafness/dystonia peptide gene mutation that causes dystonia in female carriers of Mohr-Tranebjaerg syndrome. Annals of Neurology. 50: 537-40. PMID 11601506 DOI: 10.1002/Ana.1160 |
0.246 |
|
| 1972 |
Coyle JT, Wooten GF. Rapid axonal transport of tyrosine hydroxylase and dopamine- -hydroxylase. Brain Research. 44: 701-4. PMID 4116449 DOI: 10.1016/0006-8993(72)90340-X |
0.246 |
|
| 2011 |
Barrett MJ, Wylie SA, Harrison MB, Wooten GF. Handedness and motor symptom asymmetry in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 1122-4. PMID 20861062 DOI: 10.1136/jnnp.2010.209783 |
0.246 |
|
| 1998 |
Currie LJ, Harrison MB, Trugman JM, Bennett JP, Wooten GF. Early morning dystonia in Parkinson's disease. Neurology. 51: 283-5. PMID 9674823 |
0.244 |
|
| 2004 |
Currie LJ, Harrison MB, Trugman JM, Bennett JP, Wooten GF. Postmenopausal estrogen use affects risk for Parkinson disease. Archives of Neurology. 61: 886-8. PMID 15210525 DOI: 10.1001/archneur.61.6.886 |
0.244 |
|
| 1980 |
Cheng CH, Wooten GF. A highly sensitive radioenzymatic assay for simultaneous estimation of norepinephrine, dopamine, and epinephrine. Journal of Pharmacological Methods. 3: 333-44. PMID 7392663 DOI: 10.1016/0160-5402(80)90075-3 |
0.242 |
|
| 2016 |
Crowell JL, Wooten GF, Barrett MJ. MM1-Type Sporadic Creutzfeldt-Jakob Disease With Early Behavioral Changes and Prolonged Symptom Duration. The Journal of Neuropsychiatry and Clinical Neurosciences. 28: e31-2. PMID 27093388 DOI: 10.1176/Appi.Neuropsych.15120404 |
0.237 |
|
| 2004 |
Ranta A, Wooten GF. Hyponatremia due to an additive effect of carbamazepine and thiazide diuretics. Epilepsia. 45: 879. PMID 15230718 DOI: 10.1111/J.0013-9580.2004.00604.X |
0.237 |
|
| 1983 |
Zucker DK, Wooten GF, Lothman EW. Blood-brain barrier changes with kainic acid-induced limbic seizures. Experimental Neurology. 79: 422-33. PMID 6822273 DOI: 10.1016/0014-4886(83)90223-6 |
0.234 |
|
| 2017 |
Groth CL, Pusso A, Sperling SA, Huss DS, Elias WJ, Wooten GF, Barrett MJ. Capgras Syndrome in Advanced Parkinson's Disease. The Journal of Neuropsychiatry and Clinical Neurosciences. appineuropsych170300. PMID 29132271 DOI: 10.1176/appi.neuropsych.17030052 |
0.233 |
|
| 2005 |
Nutt JG, Wooten GF. Clinical practice. Diagnosis and initial management of Parkinson's disease. The New England Journal of Medicine. 353: 1021-7. PMID 16148287 DOI: 10.1056/Nejmcp043908 |
0.231 |
|
| 1986 |
Stringer JL, Lothman EW, Wooten GF. Local synaptic interactions in the rat striatum in vitro: a quantitative analysis based on unit discharges. Experimental Neurology. 94: 489-96. PMID 3780902 DOI: 10.1016/0014-4886(86)90232-3 |
0.23 |
|
| 2006 |
Holroyd S, Wooten GF. Preliminary FMRI evidence of visual system dysfunction in Parkinson's disease patients with visual hallucinations. The Journal of Neuropsychiatry and Clinical Neurosciences. 18: 402-4. PMID 16963591 DOI: 10.1176/Jnp.2006.18.3.402 |
0.222 |
|
| 1980 |
Wooten GF, Cheng CH. Transport and turnover of acetylcholinesterase and choline acetyltransferase in rat sciatic nerve and skeletal muscle. Journal of Neurochemistry. 34: 359-66. PMID 6157781 DOI: 10.1111/J.1471-4159.1980.Tb06605.X |
0.22 |
|
| 2010 |
Du X, Wooten GF, Matsumoto JA, Phillips LH. Central nervous system involvement in axonal Charcot-Marie-Tooth disease. Muscle & Nerve. 41: 148-50. PMID 19813192 DOI: 10.1002/Mus.21524 |
0.217 |
|
| 1977 |
Wooten GF, Weise VK, Kopin IJ. Norepinephrine synthesis contributes to the accumulation of catecholamines after ligation of rat sciatic nerves. Brain Research. 136: 174-7. PMID 73401 DOI: 10.1016/0006-8993(77)90143-3 |
0.216 |
|
| 2003 |
Nutt JG, Burchiel KJ, Comella CL, Jankovic J, Lang AE, Laws ER, Lozano AM, Penn RD, Simpson RK, Stacy M, Wooten GF. Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology. 60: 69-73. PMID 12525720 DOI: 10.1212/Wnl.60.1.69 |
0.21 |
|
| 2001 |
Wittmann A, Wooten GF. Amoxicillin-induced aseptic meningitis. Neurology. 57: 1734. PMID 11706130 DOI: 10.1212/Wnl.57.9.1734 |
0.204 |
|
| 1999 |
Parker WD, Swerdlow RH, Parks JK, Davis JN, Trimmer P, Bennett JP, Wooten GF. Parkinson disease in twins. Jama. 282: 1328; author reply 1. PMID 10527169 DOI: 10.1001/jama.282.14.1328 |
0.196 |
|
| 1984 |
Spencer SE, Wooten GF. Altered pharmacokinetics of L-dopa metabolism in rat striatum deprived of dopaminergic innervation. Neurology. 34: 1105-8. PMID 6540390 |
0.194 |
|
| 1991 |
Granner MA, Wooten GF. Neuroleptic malignant syndrome or parkinsonism hyperpyrexia syndrome. Seminars in Neurology. 11: 228-35. PMID 1947485 DOI: 10.1055/s-2008-1041226 |
0.194 |
|
| 2004 |
Morgan JC, Winter WC, Wooten GF. Amphetamine-induced chorea in attention deficit-hyperactivity disorder. Movement Disorders : Official Journal of the Movement Disorder Society. 19: 840-2. PMID 15254949 DOI: 10.1002/Mds.20081 |
0.192 |
|
| 1981 |
Henderson VW, Wooten GF. Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade? Neurology. 31: 132-7. PMID 6110195 DOI: 10.1212/WNL.31.2.132 |
0.192 |
|
| 1990 |
Trugman JM, Pronsky CJ, Wooten GF. Basal ganglia dopamine depletion does not alter D1 dopamine receptor binding properties. Advances in Neurology. 53: 107-10. PMID 2146858 |
0.187 |
|
| 1988 |
Beckstead RM, Wooten GF, Trugman JM. Distribution of D1 and D2 dopamine receptors in the basal ganglia of the cat determined by quantitative autoradiography. The Journal of Comparative Neurology. 268: 131-45. PMID 2964456 DOI: 10.1002/cne.902680113 |
0.174 |
|
| 1997 |
Wooten GF. Functional anatomical and behavioral consequences of dopamine receptor stimulation. Annals of the New York Academy of Sciences. 835: 153-6. PMID 9616770 DOI: 10.1111/j.1749-6632.1997.tb48626.x |
0.171 |
|
| 1980 |
Sundermann RH, Wooten GF. Biochemical properties of spiperone binding to rat brain membranes. Pharmacology. 21: 295-305. PMID 6106952 |
0.171 |
|
| 1989 |
Trugman JM, Arnold WS, Touchet N, Wooten GF. D1 dopamine agonist effects assessed in vivo with [14C]-2-deoxyglucose autoradiography. The Journal of Pharmacology and Experimental Therapeutics. 250: 1156-60. PMID 2674418 |
0.17 |
|
| 2012 |
Wylie SA, van den Wildenberg W, Ridderinkhof KR, Claassen DO, Wooten GF, Manning CA. Differential susceptibility to motor impulsivity among functional subtypes of Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 83: 1149-54. PMID 22917670 DOI: 10.1136/Jnnp-2012-303056 |
0.17 |
|
| 1987 |
Trugman JM, Wooten GF. Selective D1 and D2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxydopamine substantia nigra lesions. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 7: 2927-35. PMID 3114439 |
0.169 |
|
| 1991 |
Trugman JM, James CL, Wooten GF. D1/D2 dopamine receptor stimulation by L-dopa. A [14C]-2-deoxyglucose autoradiographic study. Brain : a Journal of Neurology. 114: 1429-40. PMID 1829645 DOI: 10.1093/brain/114.3.1429 |
0.168 |
|
| 2005 |
Holroyd S, Currie LJ, Wooten GF. Depression is associated with impairment of ADL, not motor function in Parkinson disease. Neurology. 64: 2134-5. PMID 15985588 DOI: 10.1212/01.WNL.0000165958.12724.0D |
0.168 |
|
| 2006 |
Wooten GF. Margaret M. Hoehn, 24 November 1930-16 July 2005 Movement Disorders. 21: 131-131. DOI: 10.1002/Mds.20839 |
0.167 |
|
| 2001 |
Currie LJ, Harrison MB, Trugman JM, Bennett JP, Swerdlow RH, Manning CA, Wooten GF. Maternal age is not a risk factor for Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 71: 130-1. PMID 11439965 DOI: 10.1136/jnnp.71.1.130 |
0.166 |
|
| 2005 |
Elm JJ, Goetz CG, Ravina B, Shannon K, Wooten GF, Tanner CM, Palesch YY, Huang P, Guimaraes P, Kamp C, Tilley BC, Kieburtz K. A responsive outcome for Parkinson's disease neuroprotection futility studies. Annals of Neurology. 57: 197-203. PMID 15668964 DOI: 10.1002/Ana.20361 |
0.165 |
|
| 2006 |
Lang AE, Langston JW, Stoessl AJ, Brodsky M, Brooks DJ, Dhawan V, Elias WJ, Lozano AM, Moro E, Nutt JG, Stacy M, Turner D, Wooten GF. GDNF in treatment of Parkinson's disease: response to editorial. The Lancet. Neurology. 5: 200-2. PMID 16488373 DOI: 10.1016/S1474-4422(06)70359-3 |
0.164 |
|
| 1994 |
Trugman JM, Leadbetter R, Zalis ME, Burgdorf RO, Wooten GF. Treatment of severe axial tardive dystonia with clozapine: case report and hypothesis. Movement Disorders : Official Journal of the Movement Disorder Society. 9: 441-6. PMID 7969212 DOI: 10.1002/mds.870090411 |
0.164 |
|
| 1981 |
Wooten GF, Collins RC. Metabolic effects of unilateral lesion of the substantia nigra. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 1: 285-91. PMID 7264720 |
0.163 |
|
| 1983 |
Geary WA, Wooten GF. Quantitative film autoradiography of opiate agonist and antagonist binding in rat brain. The Journal of Pharmacology and Experimental Therapeutics. 225: 234-40. PMID 6300375 |
0.162 |
|
| 1982 |
Cheng CH, Wooten GF. Dopamine turnover estimated by simultaneous LCEC assay of dopamine and dopamine metabolites. Journal of Pharmacological Methods. 8: 123-33. PMID 7144209 DOI: 10.1016/0160-5402(82)90066-3 |
0.16 |
|
| 1984 |
Spencer SE, Wooten GF. Pharmacologic effects of L-dopa are not closely linked temporally to striatal dopamine concentration. Neurology. 34: 1609-11. PMID 6504335 |
0.159 |
|
| 2004 |
Wooten GF, Currie LJ, Bovbjerg VE, Lee JK, Patrie J. Are men at greater risk for Parkinson's disease than women? Journal of Neurology, Neurosurgery, and Psychiatry. 75: 637-9. PMID 15026515 DOI: 10.1136/jnnp.2003.020982 |
0.158 |
|
| 1981 |
Cheng CH, Wooten GF. Simultaneous radioenzymatic assay of dopamine and dihydroxyphenylacetic acid: an index of in vivo dopamine release. Journal of Pharmacological Methods. 5: 165-73. PMID 7230840 DOI: 10.1016/0160-5402(81)90008-5 |
0.157 |
|
| 1994 |
Adams RE, Wooten GF. Regional cerebral glucose utilization in withdrawal following systemic and intracerebroventricular sufentanil administration. Neurochemical Research. 19: 1243-8. PMID 7891840 DOI: 10.1007/BF01006813 |
0.154 |
|
| 1984 |
Rubin EH, Wooten GF. The behavioral and biochemical effects of lithium on dopaminergic agonist-induced supersensitivity. Psychopharmacology. 84: 217-20. PMID 6438680 DOI: 10.1007/BF00427448 |
0.153 |
|
| 1990 |
Trugman JM, Wooten GF. Functional consequences of dopamine receptor stimulation Current Opinion in Neurology and Neurosurgery. 3: 548-551. |
0.151 |
|
| 2006 |
Tilley BC, Palesch YY, Kieburtz K, Ravina B, Huang P, Elm JJ, Shannon K, Wooten GF, Tanner CM, Goetz GC. Optimizing the ongoing search for new treatments for Parkinson disease: using futility designs. Neurology. 66: 628-33. PMID 16534099 DOI: 10.1212/01.Wnl.0000201251.33253.Fb |
0.143 |
|
| 1985 |
Geary WA, Wooten GF. Regional saturation studies of [3H]naloxone binding in the naive, dependent and withdrawal states. Brain Research. 360: 214-23. PMID 4075170 DOI: 10.1016/0006-8993(85)91237-5 |
0.142 |
|
| 1982 |
Rubin EH, Wooten GF. Neuroleptic- but not denervation-induced dopamine supersensitivity is blocked by lithium Neurology. 32: A 65. |
0.14 |
|
| 2001 |
Holroyd S, Currie L, Wooten GF. Prospective study of hallucinations and delusions in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 70: 734-8. PMID 11385005 DOI: 10.1136/jnnp.70.6.734 |
0.138 |
|
| 1975 |
Wooten GF, Jacobowitz DM, Saavedra JM, Axelrod J. Localization of extraneuronal dopamine-beta-hydroxylase in rat salivary gland by immunofluorescence histochemistry. Journal of Neurochemistry. 24: 1107-10. PMID 1092811 DOI: 10.1111/J.1471-4159.1975.Tb03884.X |
0.138 |
|
| 1993 |
Wooten GF, Lopes MB, Harris WO, Reagan TJ, Vandenberg SR. Pallidoluysian atrophy: dystonia and basal ganglia functional anatomy. Neurology. 43: 1764-8. PMID 8414028 DOI: 10.1212/Wnl.43.9.1764 |
0.135 |
|
| 1983 |
Wooten GF, Collins RC. Effects of dopaminergic stimulation on functional brain metabolism in rats with unilateral substantia nigra lesions. Brain Research. 263: 267-75. PMID 6839175 DOI: 10.1016/0006-8993(83)90319-0 |
0.133 |
|
| 1984 |
Horne MK, Cheng CH, Wooten GF. The cerebral metabolism of L-dihydroxyphenylalanine. An autoradiographic and biochemical study. Pharmacology. 28: 12-26. PMID 6701184 |
0.131 |
|
| 1980 |
Wooten GF, Collins RC. Effects of dopaminergic denervation of striatum on regional cerebral glucose utilization Neurology. 30: PP 41. |
0.13 |
|
| 1982 |
Wooten GF, DiStefano P, Collins RC. Regional cerebral glucose utilization during morphine withdrawal in the rat. Proceedings of the National Academy of Sciences of the United States of America. 79: 3360-4. PMID 6954484 |
0.129 |
|
| 1987 |
Geary WA, Wooten GF, Perlin JB, Lothman EW. In vitro and in vivo distribution and binding of phenytoin to rat brain. The Journal of Pharmacology and Experimental Therapeutics. 241: 704-13. PMID 3572819 |
0.127 |
|
| 2009 |
Swerdlow RH, Miller BB, Lopes MB, Mandell JW, Wooten GF, Damgaard P, Manning C, Fowler M, Brashear HR. Autosomal dominant subcortical gliosis presenting as frontotemporal dementia. Neurology. 72: 260-7. PMID 19153373 DOI: 10.1212/01.Wnl.0000339484.61490.A4 |
0.126 |
|
| 1987 |
Pollack AE, Wooten GF. Effects of sodium on cell surface and intracellular 3H-naloxone binding sites. Life Sciences. 41: 385-90. PMID 3037224 DOI: 10.1016/0024-3205(87)90212-8 |
0.121 |
|
| 1975 |
Wooten G, Hanson T, Lamprecht F. Elevated serum dopamine-beta-hydroxylase activity in rats with inherited diabetes insipidus. Journal of Neural Transmission. 36: 107-12. PMID 1151368 DOI: 10.1007/BF01256758 |
0.121 |
|
| 1974 |
Coyle JT, Wooten GF, Axelrod J. Evidence for extranoradrenergic dopamine-beta-hydroxylase activity in rat salivary gland. Journal of Neurochemistry. 22: 923-9. PMID 4152880 DOI: 10.1111/j.1471-4159.1974.tb04316.x |
0.118 |
|
| 1975 |
Ciaranello RD, Wooten GF, Axwlrod J. Regulation of dopamine beta-hydroxylase in rat adrenal glands. The Journal of Biological Chemistry. 250: 3204-11. PMID 235542 |
0.114 |
|
| 1973 |
Wooten GF, Thoa NB, Kopin IJ, Axelrod J. Enhanced release of dopamine -hydroxylase and norepinephrine from sympathetic nerves by dibutyryl cyclic adenosine 3', 5'-monophosphate and theophylline. Molecular Pharmacology. 9: 178-83. PMID 4351235 |
0.113 |
|
| 1973 |
Lamprecht F, Wooten GF. Effect of hypophysectomy on serum dopamine-beta-hydroxylase activity in rat. Endocrinology. 92: 1543-6. PMID 4348656 DOI: 10.1210/endo-92-5-1543 |
0.113 |
|
| 1976 |
Lamprecht F, Wooten GF. Serum dopamine-beta-hydroxylase activity in rat during post-natal development. Journal of Neural Transmission. 39: 301-7. PMID 993792 DOI: 10.1007/BF01266306 |
0.11 |
|
| 1976 |
Kanter W, Wooten GF, Eldridge R. Dopamine beta-hydroxylase and the torsion dystonias. Advances in Neurology. 14: 303-5. PMID 941775 |
0.11 |
|
| 1992 |
Wolf SS, Brashear HR, Levesque CA, Wooten GF. Quantitative autoradiography of hemicholinium-3 binding sites in human amygdala. Brain Research. 574: 349-52. PMID 1322225 DOI: 10.1016/0006-8993(92)90840-6 |
0.108 |
|
| 1985 |
Geary WA, Wooten GF. Similar functional anatomy of spontaneous and precipitated morphine withdrawal. Brain Research. 334: 183-6. PMID 4039621 DOI: 10.1016/0006-8993(85)90585-2 |
0.108 |
|
| 1997 |
Soykan I, Sarosiek I, Shifflett J, Wooten GF, McCallum RW. Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 12: 952-7. PMID 9399220 DOI: 10.1002/mds.870120618 |
0.107 |
|
| 1985 |
Geary WA, Wooten GF. Regional tritium quenching in quantitative autoradiography of the central nervous system. Brain Research. 336: 334-6. PMID 4005589 DOI: 10.1016/0006-8993(85)90662-6 |
0.107 |
|
| 1974 |
Naftchi NE, Wooten GF, Lowman EW, Axelrod J. Relationship between serum dopamine-beta-hydroxylase activity, catecholamine metabolism, and hemodynamic changes during paroxysmal hypertension in quadriplegia. Circulation Research. 35: 850-61. PMID 4430080 DOI: 10.1161/01.RES.35.6.850 |
0.106 |
|
| 1978 |
Wooten GF, Park DH, Joh TH, Reis DJ. Immunochemical demonstration of reversible reduction in choline acetyltransferase concentration in rat hypoglossal nucleus after hypoglossal nerve transection. Nature. 275: 324-5. PMID 692712 DOI: 10.1038/275324A0 |
0.106 |
|
| 1982 |
Mintun M, Wooten GF, Raichle ME. A quantitative model for the measurement of brain receptor binding and number in vivo with positron emission tomography Annals of Neurology. 12: No. P28. |
0.106 |
|
| 1974 |
Wooten GF, Ciaranello RD. Proportionally between dopamine-beta-hydroxylase activity and immunoreactive protein concentration in human serum. Pharmacology. 12: 272-82. PMID 4449890 |
0.097 |
|
| 2012 |
Bruno MK, Wooten GF. Hypertrophic olivary degeneration. Archives of Neurology. 69: 274-5. PMID 22332198 DOI: 10.1001/archneurol.2011.657 |
0.096 |
|
| 1981 |
Wooten GF, Horne MK. An in vivo model for imaging forebrain dopamine systems in humans. Transactions of the American Neurological Association. 106: 226-8. PMID 7349001 |
0.094 |
|
| 1974 |
Wooten GF, Ciaranello RD. Proportionality between dopamine β hydroxylase activity and immunoreactive protein concentration in human serum Pharmacology. 12: 272-282. |
0.093 |
|
| 1987 |
Geary WA, Wooten GF. In vivo tracer studies of glucose metabolism, cerebral blood flow, and protein synthesis in naloxone precipitated morphine withdrawal. Neurochemical Research. 12: 573-80. PMID 3614509 DOI: 10.1007/BF00971004 |
0.092 |
|
| 1974 |
Naftchi NE, Wooten GF, Lowman EW, Axelrod J. Serum dopamine β hydroxylase activity, catecholamine metabolism, and hemodynamic changes during hypertension in quadriplegia Pharmacologist. 16: no.253. |
0.091 |
|
| 1973 |
Wooten GF, Cardon PV. Plasma dopamine- -hydroxylase activity. Elevation in man during cold pressor test and exercise. Archives of Neurology. 28: 103-6. PMID 4405121 DOI: 10.1001/archneur.1973.00490200051006 |
0.088 |
|
| 1974 |
Lamprecht F, Eichelman BS, Williams RB, Wooten GF, Kopin IJ. Serum dopamine-beta-hydroxylase (DBH) activity and blood pressure response of rat strains to shock-induced fighting. Psychosomatic Medicine. 36: 298-303. PMID 4472301 DOI: 10.1097/00006842-197407000-00003 |
0.087 |
|
| 1997 |
Currie LJ, Bennett JP, Harrison MB, Trugman JM, Wooten GF. Clinical correlates of sleep benefit in Parkinson's disease. Neurology. 48: 1115-7. PMID 9109914 |
0.086 |
|
| 2000 |
Swerdlow RH, Golbe LI, Parks JK, Cassarino DS, Binder DR, Grawey AE, Litvan I, Bennett JP, Wooten GF, Parker WD. Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear palsy. Journal of Neurochemistry. 75: 1681-4. PMID 10987850 DOI: 10.1046/J.1471-4159.2000.0751681.X |
0.081 |
|
| 1979 |
Wooten GF, Cheng CH. Behavioral tolerance to chronic apomorphine administration in rats. Transactions of the American Neurological Association. 104: 219-21. PMID 576005 |
0.074 |
|
| 1985 |
Geary WA, Toga AW, Wooten GF. Quantitative film autoradiography for tritium: methodological considerations. Brain Research. 337: 99-108. PMID 4005611 DOI: 10.1016/0006-8993(85)91613-0 |
0.072 |
|
| 2004 |
Swerdlow RH, Juel VC, Wooten GF. Dystonia with and without deafness is caused by TIMM8A mutation. Advances in Neurology. 94: 147-54. PMID 14509668 |
0.067 |
|
| 1989 |
Klein P, Haley EC, Wooten GF, VandenBerg SR. Focal cerebral infarctions associated with perivascular tumor infiltrates in carcinomatous leptomeningeal metastases. Archives of Neurology. 46: 1149-52. PMID 2552969 DOI: 10.1001/Archneur.1989.00520460145030 |
0.059 |
|
| 1998 |
Nygaard TG, Wooten GF. Dopa-responsive dystonia: some pieces of the puzzle are still missing. Neurology. 50: 853-5. PMID 9566361 |
0.055 |
|
| 1975 |
Wooten GF, Kopin IJ, Axelrod J. Effects of colchicine and vinblastine on axonal transport and transmitter release in sympathetic nerves. Annals of the New York Academy of Sciences. 253: 528-34. PMID 50036 DOI: 10.1111/J.1749-6632.1975.Tb19226.X |
0.051 |
|
| 1980 |
Henderson V, Taylor D, Wooten GF. The neuroleptic malignant syndrome: A unique case report and hypothesis of pathogenesis Neurology. 30: PP 47. |
0.049 |
|
| 1981 |
Zucker DK, Wooten GF, Lothman EW, Olney JW. Neuropathological changes associated with intravenous kainic acid Journal of Neuropathology and Experimental Neurology. 40: No. 76. |
0.047 |
|
| 1975 |
Thoa NB, Wooten GF, Axelrod J, Kopin IJ. On the mechanism of release of norepinephrine from sympathetic nerves induced by depolarizing agents and sympathomimetic drugs. Molecular Pharmacology. 11: 10-8. PMID 1117862 |
0.046 |
|
| 1985 |
Wooten GF, Spencer SE. Altered pharmacokinetics of l-dopa metabolism Neurology. 35: 940-940. DOI: 10.1212/WNL.35.6.940 |
0.043 |
|
| 1974 |
Wooten GF, Saavedra JM. Axonal transport of phenylethanolamine-N-methyltransferase in toad sciatic nerve. Journal of Neurochemistry. 22: 1059-64. PMID 4211826 |
0.041 |
|
| 1981 |
Lothman EW, Collins RC, Zucker DK, Wooten GF. Mossy fiber lesions attenuate kainic acid-induced limbic seizures Epilepsia. 22: 229-230. |
0.041 |
|
| 1974 |
Wooten GF. Exocytosis at sympathetic nerve terminals Biochemical Pharmacology. 23: 402-404. |
0.04 |
|
| 1973 |
Wooten GF, Coyle JT. Axonal transport of catecholamine synthesizing and metabolizing enzymes. Journal of Neurochemistry. 20: 1361-71. PMID 4123797 DOI: 10.1111/j.1471-4159.1973.tb00248.x |
0.036 |
|
| 1982 |
Rubin EH, Wooten GF. Lithium-ketamine interaction: an animal study of potential clinical and theoretical interest. Journal of Clinical Psychopharmacology. 2: 211-4. PMID 7096610 |
0.035 |
|
| 1977 |
Natelson BH, Kotchen TA, Stokes PE, Wooten GF. Relationship between avoidance-induced arousal and plasma DBH, glucose and renin activity. Physiology & Behavior. 18: 671-7. PMID 408830 DOI: 10.1016/0031-9384(77)90065-8 |
0.033 |
|
| 1970 |
Reis DJ, Wooten GF. The relationship of blood flow to myoglobin, capillary density, and twitch characteristics in red and white skeletal muscle in cat. The Journal of Physiology. 210: 121-35. PMID 5500770 DOI: 10.1113/jphysiol.1970.sp009199 |
0.031 |
|
| 1978 |
Wooten GF, Petito CK. Brain abnormalities in chronic renal failure: A comparison of treatment by hemodialysis alone versus cadaver renal transplant with hemodialysis Annals of Neurology. 4: 171. |
0.03 |
|
| 1972 |
Wooten GF, Reis DJ. Blood flow in red and white muscle in early development. The International Journal of Neuroscience. 3: 155-64. PMID 4572700 DOI: 10.3109/00207457209147018 |
0.029 |
|
| 1982 |
Lothman EW, Stein DA, Wooten GF, Zucker DK. Potential mechanisms underlying the destruction of dentate gyrus granule cells by colchicine. Experimental Neurology. 78: 293-302. PMID 7140899 DOI: 10.1016/0014-4886(82)90048-6 |
0.028 |
|
| 1978 |
Wooten GF, Petito CK. Brain pathology in chronic renal failure: treatment with hemodialysis versus cadaver renal transplant. Transactions of the American Neurological Association. 103: 121-3. PMID 390832 |
0.027 |
|
| 1981 |
Henderson VW, Wooten GF. Neuroleptic malignant syndrome Neurology. 31: 1500-1500. DOI: 10.1212/WNL.31.11.1500-a |
0.027 |
|
| 1976 |
Reis DJ, Wooten GF. Blood flow in red and white muscle: relationship to metabolism development and behavior. Progress in Brain Research. 44: 385-402. PMID 188073 DOI: 10.1016/S0079-6123(08)60747-5 |
0.027 |
|
| 1981 |
Henderson VW, Wooten GF. Reply from the authors: Neuroleptic malignant syndrome Neurology. 31: 1500. |
0.024 |
|
| 1969 |
Reis DJ, Wooten GF, Moorhead D. Behavioral correlates of blood flow and myoglobin concentration in skeletal muscle in cat. Transactions of the American Neurological Association. 94: 326-8. PMID 4313965 |
0.023 |
|
| 1973 |
Matta RJ, Wooten GF. Pharmacology of fusaric acid in man. Clinical Pharmacology and Therapeutics. 14: 541-6. PMID 4269210 |
0.02 |
|
| 1972 |
Wooten GF, Reis DJ. Blood flow in extraocular muscle of cat. Archives of Neurology. 26: 350-2. PMID 5015593 DOI: 10.1001/archneur.1972.00490100080008 |
0.015 |
|
| 1969 |
Reis DJ, Moorhead D, Wooten GF. Differential regulation of blood flow to red and white muscle in sleep and defense behavior. The American Journal of Physiology. 217: 541-6. PMID 4308038 DOI: 10.1152/AJPLEGACY.1969.217.2.541 |
0.013 |
|
| 2009 |
Wooten GF. Principles and Practice of Movement Disorders Journal of Neuro-Ophthalmology. 29: 255. DOI: 10.1097/01.WNO.0000360543.85024.82 |
0.011 |
|
| 1967 |
Reis DJ, Wooten GF, Hollenberg M. Differences in nutrient blood flow of red and white skeletal muscle in the cat. The American Journal of Physiology. 213: 592-6. PMID 6036776 DOI: 10.1152/AJPLEGACY.1967.213.3.592 |
0.011 |
|
| 2013 |
Kassell NF, Wooten GF. Gamma Knife thalamotomy. Journal of Neurosurgery. 119: 531-2. PMID 23790117 DOI: 10.3171/2013.4.JNS13802 |
0.01 |
|
| 2006 |
Holroyd S, Currie LJ, Wooten GF. Reply from the authors [10] Neurology. 66: 956. |
0.01 |
|
| 1995 |
Wooten GF. Eric w. lothman (1947-1995) Neurology. 45: 1625-1625. |
0.01 |
|
| 1968 |
Reis DJ, Moorhead D, Wooten GF. Redistribution of visceral and cerebral blood flow in the REM phase of sleep. Neurology. 18: 282. PMID 5690348 |
0.01 |
|
| Hide low-probability matches. |